Consistently, genome-wide CRISPR screenings by DepMap across different lung cancer types revealed that lung cancer cells are generally more sensitive to MBD6 depletion, while MBD5 is not essential for lung cancer cell viability (Fig. 4C). This evidence concerns the gene MBD6 and lung cancer.